ABC | Volume 110, Nº4, Abril 2018

Artigo Original Cartolano et al LAP e tamanho da lipoproteína Arq Bras Cardiol. 2018; 110(4):339-347 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 10. KahnHS.The“lipidaccumulationproduct”performsbetterthanthebodymass indexforrecognizingcardiova scularrisk:apopulation-basedcomparison.BMC CardiovascDisord. 2005 Sep 8;5:26. doi: 10.1186/1471-2261-5-26. 11. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care. 2006;29(1):151- 3. doi: https://doi.org/10.2337/diacare.29.01.06.dc05-1805. 12. Oh JY, Sung YA, Lee HJ. The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women. Diabet Med. 2013;30(4):436-42. doi: 10.1111/dme.12052. 13. Tankó LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation. 2005;111(15):1883-90. doi: 10.1161/01.CIR.0000161801.65408.8D. 14. Lwow F, Jedrzejuk D, Milewicz A, Szmigiero L. Lipid accumulation product (LAP) as a criterion for the identification of the healthy obesity phenotype in postmenopausal women. ExpGerontol. 2016 Sep;82:81-7. doi: 10.1016/j. exger.2016.06.007. 15. Nascimento JX, Chein MB, Sousa RM, Ferreira AS, Navarro PA, Brito LM. Importance of lipid accumulation product index as marker of CVD risk in PCOSwomen. Lipids HealthDis. 2015 Jun 24;14:62. doi: 10.1186/s12944- 015-0061-y. 16. Macut D, Tziomalos K, Antic-Bozic I, Bjekic-Macut J, Katsikis I, Papadakis E, et al. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. Hum Reprod. 2016 Jun;31(6):1347-53. doi: 10.1093/humrep/dew076. 17. Costa EC, Ferezini De Sá JC, Soares EM, Lemos TM, Maranhão TM, Azevedo GD. Evaluation of cardiovascular risk by the LAP index in non-obese patients withpolycysticovarysyndrome.ArqBrasEndocrinolMetab.2010;54(7):630- 5. doi: http://dx.doi.org/10.1590/S0004-27302010000700007. 18. Wehr E, Pilz S, Boehm BO, März W, Obermayer-Pietsch B. The lipid accumulation product is associated with increased mortality in normal weight postmenopausal women. Obesity (Silver Spring). 2011;19(9):1873- 80. doi: 10.1038/oby.2011.42. 19. Maturana MA, Moreira RM, Spritzer PM. Lipid accumulation product (LAP) is related to androgenicity and cardiovascular risk factors in postmenopausal women.Maturitas.2011;70(4):395-9.doi:10.1016/j.maturitas.2011.09.012. 20. Pontes AG, Rehme MF, Martins AM, Micussi MT, Maranhão TM, Pimenta WP, et al. Insulin resistance in women with polycystic ovary syndrome: relationship with anthropometric and biochemical variables. Rev Bras Ginecol Obstet. 2012;34(2):74-9. doi: http://dx.doi.org/10.1590/S0100- 72032012000200006. 21. D´Agostino RB, Vasan RS, Pecina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: The FraminghamHeart Study. Circulation. 2008;117(6):743-53. doi: 10.1161/ CIRCULATIONAHA.107.699579. 22. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women 2011 update: a guideline from the American Heart Association. Circulation. 2011;123(11):1243-62. doi: 10.1161/CIR.0b013e31820faaf8. Erratumin:Circulation.2011;123(22):e624;Circulation.2011;124(16):e427. 23. FriedewaldWT, Levy RI, FredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. PMID: 4337382. 24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration inman. Diabetologia. 1985;28(7):412-9. PMID: 3899825. 25. Koba S, Hirano T, Kondo T, Shibata M, Suzuki H, Murakami M, et al. Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease. Am Heart J. 2002;144(6):1026-35. doi: 10.1067/mhj.2002.126119. 26. Mirmiran P, Bahadoran Z, Azizi F. Lipid accumulation product is associated with insulin resistance, lipid peroxidation, and systemic inflammation in type 2 diabetic patients. Endocrinol Metab (Seoul). 2014;29(4):443-9. doi: 10.3803/EnM.2014.29.4.443. 27. Kwon SW, Yoon SJ, Kang TS, Kwon HM, Kim JH, Rhee J, et al. Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome. Yonsei Med J. 2006; 47(3): 405-14. doi: 10.3349/ymj.2006.47.3.405. 28. Shen H, Xu L, Lu J, Hao T, Ma C, Yang H, et al. Correlation between small dense low-density lipoprotein cholesterol and carotid artery intima-media thickness in a healthy Chinese population. Lipids Health Dis. 2015 Oct 29;14:137. doi: 10.1186/s12944-015-0143-x. 29. Toth PP, Patti AM, NikolicD, Giglio RV, CastellinoG, Biancucci T, et al. Bergamot reducesplasmalipids,atherogenicsmalldenseLDL,andsubclinicalatherosclerosis in subjects withmoderate hypercholesterolemia: a 6months prospective study. FrontPharmacol.2016Jan6;6:299.doi:10.3389/fphar.2015.00299. 30. ShenH, Zhou J, Shen G, Yang H, Lu Z, Wang H. Correlation between serum levels of small, dense low-density lipoprotein cholesterol and carotid stenosis in cerebral infarction patients >65 years of age. Ann Vasc Surg. 2014;28(2):375-80. doi: 10.1016/j.avsg.2013.01.029. 31. Eppinga RN, Hartman MH, van Veldhuisen DJ, Lexis CP, Connelly MP, Lipsic E, et al. Effect of metformin treatment on lipoprotein subfractions in non-diabetic patients with acute myocardial infarction: a glycometabolic intervention as adjunct to primary coronary intervention in ST elevation myocardial infarction (GIPS-III) trial. PLoS One. 2016;11(1):e0145719. doi: 10.1371/journal.pone.0145719. 32. Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, et al. High-density lipoprotein subpopulation profile and coronary heart disease prevalence inmale participants of the FraminghamOffspring Study. Arterioscler Thromb Vasc Biol. 2004;24(11):2181-7. doi: 10.1161/01. ATV.0000146325.93749.a8. 33. O’Neill F, McLoughlin E, Riwanto M, Manz J, Adler A, Sutill E, et al. Reproducibility and biological variability of HDL’s vascular functional assays. Atherosclerosis. 2015;241(2):588-94. doi: 10.1016/j. atherosclerosis.2015.06.005. 34. El Harchaoui K, Arsenault BJ, Franssen R, Despres JP, HovinghGK, Stroes ES, et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med. 2009;150(2):84-93. doi: 10.7326/0003-4819-150- 2-200901200-00006. 35. Pankow JS, Duncan BB, SchmidtMI, BallantyneCM, Couper DJ, Hoogeveen RC, et al. Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2004;27(1):77-82. doi: https://doi.org/10.2337/diacare.27.1.77. 36. Il’yasova D, Wang F, D’Agostino RB Jr, Hanley A, Wagenknecht LE. Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose. Diabetologia. 2010;53(5):8668-74. doi: 10.1007/ s00125-010-1657-4. 37. Sarafidis PA, Bakris GL. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/ insulin resistance? J Hum Hypertens. 2007;21(1):12-9. doi: 10.1038/ sj.jhh.1002103 38. Djoussé L, Biggs ML, Ix JH, Kizer JR, Lemaitre RN, Sotoodehnia N, et al. Nonesterified fatty acids and risk of sudden cardiac death in older adults. Circ Arrhythm Electrophysiol. 2012; 5(2): 273-8. doi: 10.1161/ CIRCEP.111.967661. 39. Morita S, Shimajiri Y, Sakagashira S, Furuta M, Sanke T. Effect of exposure to non-esterified fatty acid on progressive deterioration of insulin secretion in patients with Type 2 diabetes: a long-term follow-up study. Diabet Med. 2012;29(8):980-5. doi: 10.1111/j.1464-5491.2011.03566.x. 40. Sambataro M, Perseghin G, Lattuada G, Beltramello G, Luzi L, Pacini G. Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines. Acta Diabetol. 2013; 50(3): 301-7. doi: 10.1007/s00592-011-0366-x. 347